Top 50 Life Science VC Funds & Investors in Asia (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Prox Ventures
VC Fund
|
10 | China, United States, United Kingdom | Seed, Series A | Medical, Biotechnology, Health Care | $2.5M–$30M |
|
Qiming Venture Partners
VC Fund
|
8 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $4.3M–$120M |
|
Mitsubishi UFJ Capital
VC Fund
|
7 | Japan, United States, Israel | Series A, Venture - Series Unknown, Seed | Software, Information Technology, Manufacturing | $470k–$21M |
|
Linear Capital
VC Fund
|
6 | China, Singapore, United States | Seed, Angel, Series A | Artificial Intelligence, Software, Manufacturing | $1.4M–$122M |
|
SMBC Venture Capital
VC Fund
|
6 | Japan, United States, Singapore | Venture - Series Unknown, Series A, Series B | Information Technology, Software, Health Care | $800k–$34M |
|
HSG
VC Fund
|
6 | China, United States, Singapore | Series A, Series B, Seed | Artificial Intelligence, Software, Health Care | $2M–$200M |
|
IT-Farm
VC Fund
|
6 | United States, Japan, Germany | Seed, Series A, Series B | Software, Health Care, Medical | $1M–$36M |
|
Hillhouse Investment
VC Fund
|
6 | China, United States, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Software | $2.9M–$230M |
|
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
|
6 | Japan, United States, India | Series A, Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $624k–$18M |
|
Hillhouse Ventures
VC Fund
|
5 | China, Singapore, Norway | Series A, Series B, Seed | Manufacturing, Biotechnology, Health Care | $10M–$120M |
|
Huagai Capital
VC Fund
|
5 | China, United States, Hong Kong | Series A, Series B, Angel | Health Care, Biotechnology, Medical | $444k–$90M |
|
Lenovo Capital
VC Fund
|
5 | China, Hong Kong, United States | Series A, Seed, Series B | Manufacturing, Artificial Intelligence, Software | $1.4M–$150M |
|
Nissay Capital
VC Fund
|
5 | Japan, United States, Ethiopia | Venture - Series Unknown, Seed, Series A | Health Care, Software, Medical | $455k–$12M |
|
SBI Investment
VC Fund
|
5 | Japan, United States, South Korea | Series B, Series A, Venture - Series Unknown | Software, Information Technology, Financial Services | $1.3M–$62M |
|
DG Daiwa Ventures
VC Fund
|
5 | Japan, United States, India | Seed, Series A, Venture - Series Unknown | Software, FinTech, Artificial Intelligence | $367k–$19M |
|
Miyako Capital
VC Fund
|
4 | Japan, United States, United Kingdom | Series A, Seed, Series B | Medical, Biotechnology, Information Technology | $395k–$150M |
|
Baidu Ventures
VC Fund
|
4 | China, United States, Singapore | Series A, Seed, Series B | Artificial Intelligence, Health Care, Robotics | $1.5M–$123M |
|
Vinno Capital
VC Fund
|
4 | China, United States | Series A, Seed, Series B | Manufacturing, Semiconductor, Medical | $1.4M–$139M |
|
Osaka University Venture Capital
VC Fund
|
4 | Japan | Seed, Venture - Series Unknown, Series A | Biotechnology, Health Care, Medical | $480k–$19M |
|
UntroD Capital
VC Fund
|
4 | Japan, Singapore, Austria | Seed, Venture - Series Unknown, Series A | Manufacturing, Biotechnology, Health Care | $316k–$15M |
|
EFung Capital
VC Fund
|
4 | China, United States, India | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $1.4M–$100M |
|
Matrix Partners China
VC Fund
|
4 | China, United States, Singapore | Series A, Series B, Seed | Health Care, Software, Information Technology | $1.2M–$137M |
|
Dalton Venture
VC Fund
|
4 | China, India, Canada | Seed, Series A, Series B | Health Care, Medical, Biotechnology | $512k–$50M |
|
Cenova
VC Fund
|
3 | China, United States, Hong Kong | Series B, Series A, Series C | Medical, Health Care, Biotechnology | $2.9M–$100M |
|
CITIC Capital Holdings
VC Fund
|
3 | China, United States, Japan | Series A, Series B, Series C | Manufacturing, Health Care, Biotechnology | $3.2M–$230M |
|
Angel Bridge
VC Fund
|
3 | Japan | Series A, Seed, Series B | Information Technology, Software, Consulting | $792k–$47M |
|
Japan Science and Technology Agency
VC Fund
|
3 | Japan | Series A, Seed, Venture - Series Unknown | Biotechnology, Medical, Manufacturing | $975k–$15M |
|
Northern Light Venture Capital
VC Fund
|
3 | China, United States, South Korea | Series A, Series B, Venture - Series Unknown | Health Care, Medical, Biotechnology | $1.5M–$60M |
|
Longpan Investment
VC Fund
|
3 | China, United States, Cayman Islands | Series A, Seed, Series B | Health Care, Medical, Biotechnology | $14M–$60M |
|
Incubate Fund
VC Fund
|
3 | Japan, United States, India | Seed, Series A, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $288k–$20M |
|
ASBV
VC Fund
|
3 | China, Australia, Hong Kong | Seed, Series A, Angel | Health Care, Medical, Biotechnology | $471k–$34M |
|
OrbiMed
VC Fund
|
3 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $9M–$160M |
|
Lilly Asia Ventures
VC Fund
|
3 | China, United States, Hong Kong | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $14M–$308M |
|
Sherpa Healthcare Partners
VC Fund
|
3 | China, United States, Kenya | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7.2M–$128M |
|
WuXi AppTec
VC Fund
|
3 | United States, China, Israel | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $6M–$187M |
|
Jiadao Capital
VC Fund
|
3 | China | Angel, Seed, Series A | Biotechnology, Medical, Manufacturing | $1.4M–$49M |
|
Inspiration Capital
VC Fund
|
3 | China | Seed, Series A, Series B | Manufacturing, Artificial Intelligence, Sensor | $1.5M–$16M |
|
Keio Innovation Initiative
VC Fund
|
3 | Japan, United Kingdom | Series A, Seed, Venture - Series Unknown | Health Care, Medical, Biotechnology | $826k–$41M |
|
Tianjin Venture Capital
VC Fund
|
3 | China, United States | Seed, Series A | Manufacturing, Information Technology, Biotechnology | $202k–$31M |
|
ZSVC
VC Fund
|
3 | China, United States, India | Series A, Seed, Series B | Manufacturing, Medical, Health Care | $1.4M–$84M |
|
Temasek
VC Fund
|
3 | United States, China, India | Series B, Series C, Series D | Biotechnology, Health Care, Software | $28M–$460M |
|
Shenzhen Capital Group
VC Fund
|
3 | China, United States, Japan | Series A, Series B, Series C | Manufacturing, Health Care, Software | $1.5M–$156M |
|
BioVenture
VC Fund
|
3 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $4.4M–$85M |
|
MiraclePlus
VC Fund
|
3 | China, United States, Singapore | Seed, Angel, Pre-Seed | Artificial Intelligence, Software, Information Technology | |
|
Legend Capital
VC Fund
|
3 | China, United States, South Korea | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $2.9M–$200M |
|
JAFCO
VC Fund
|
3 | Japan, United States, India | Series A, Series B, Venture - Series Unknown | Information Technology, Software, Artificial Intelligence | $1.4M–$41M |
|
CD Capital
VC Fund
|
3 | China, United States | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.4M–$34M |
|
Haitang Fund
VC Fund
|
3 | China | Seed, Series A, Venture - Series Unknown | Manufacturing, Biotechnology, Medical | $1.5M–$103M |
|
ULTIMA
VC Fund
|
3 | China | Angel, Series A, Series B | Health Care, Biotechnology, Fitness | $462k–$15M |
|
Mizuho Capital
VC Fund
|
3 | Japan, United States, Singapore | Series A, Venture - Series Unknown, Series B | Information Technology, Software, Artificial Intelligence | $661k–$47M |
| Access all 50 VC funds in Asia Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential. They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many years of remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: China, United States, United Kingdom
Investor stats
- Total investments: 83
- Round size: Seed $2.5M–$30M; Series A $3M–$28M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
- Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
- Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 1200
- Round size: Series A $4.3M–$48M; Series B $8M–$90M; Series C $12M–$120M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely actively investing — fresh fund, raised $8M in 2026
Portfolio highlights
- Nice Tuan — Nice Tuan is an e-commerce platform that provides daily groceries and miscellaneous products.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- Shennapsi Artificial Intelligence Technology — Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterolmonitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Japan, United States, Israel
Investor stats
- Total investments: 689
- Round size: Seed $470k–$16M; Series A $1.2M–$21M; Venture - Series Unknown $525k–$11M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — raised $94M in 2020
Portfolio highlights
- Smart Craft —
- Luxna Biotech — Luxana Biotech is a biotechnology firm dedicated to promoting the practical use of safe and effective nucleic acid therapies. Utilizing nucleic acid chemistry technology, the company strives to provide nucleic acid medicines to patients suffering from diseases that currently lack effective treatments.
- Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Manufacturing
- Stage:Seed, Angel, Series A
- Geography: China, Singapore, United States
Investor stats
- Total investments: 96
- Round size: Seed $1.4M–$122M; Angel $1.4M–$122M; Series A $5.7M–$29M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — raised $300M in 2022
Portfolio highlights
- D-Robotics — Accelerate development with D-Robotics RDK developer kits & open-source tools for edge AI & embodied robotics. Boost performance up to 128 TOPS. Shop now!
- Xieyue Intelligent — Xieyue Intelligent focuses on the research and development of embodied intelligence technology.
- DeepPu Intelligence — DeepPu Intelligence is a high-tech enterprise specializing in the research, development, and innovation of intelligent robotic technologies. The company focuses on creating advanced robotic systems that integrate artificial intelligence, machine vision, and automation to serve a wide range of industries, including manufacturing, logistics,healthcare, and service sectors.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries and affiliates in the various business segments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Venture - Series Unknown, Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 672
- Round size: Series A $1.1M–$32M; Series B $2.3M–$34M; Venture - Series Unknown $800k–$12M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Etaily — Etaily provides e-commerce and retail solutions in the Philippines, enabling brands with end-to-end services, from store management to fulfillment.
- Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
HSG is a leading venture capital and private equity firm investing globally in the technology, healthcare, and consumer sectors.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Series A, Series B, Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 1091
- Round size: Seed $2M–$50M; Series A $3.1M–$100M; Series B $11M–$200M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $2.5B in 2024
Portfolio highlights
- Z.ai — Z.ai develops artificial intelligence models and services built upon large-scale pretrained architectures. The company offers ChatGLM, a dialogue-focused language model series designed for smooth conversation and easy integration. It also provides Ying, a text-to-video model capable of generating short video clips from text or images, and AutoGLM,a voice-driven AI agent that performs smartphone tasks based on complex user instructions. Z.ai supports integration through an API platform and offers migration assistance for developers moving from other AI ecosystems. The company’s technology stems from research at Tsinghua University’s KEG lab and emphasizes general-purpose cognitive intelligence models.
- Xinghuo Chenguang — Xinghuo Chenguang is a hard-tech company focusing on semiconductor chips and optoelectronic interconnect technologies.
- Suisheng Technology — Suisheng Technology is an innovative company specializing in AI-driven memory services, dedicated to developing intelligent solutions that help individuals and businesses capture, organize, and retrieve important information with greater efficiency and precision.
IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfolio companies, especially on the partnership with Japanese enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, Japan, Germany
Investor stats
- Total investments: 135
- Round size: Seed $1M–$7.5M; Series A $1.6M–$16M; Series B $2.5M–$36M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Ubitus — As cloud gaming enablers, Ubitus' GPU virtualization, Streaming technology and hybrid cloud deployment can serve different kinds of solutions for Telco, Game companies to quick enter cloud gaming market. Moreover, Ubitus provide Global distribution and New Media content solution for new media studio and fashion brand to help them distribute rich media contents worldwide.
- BitBiome — BitBiome is a biotechnology company focused on analyzing microbial genomes and discovering enzymes and proteins that can be applied across industries such as pharmaceuticals, food production, and sustainable manufacturing. The company uses single-cell microbial sequencing technology to study microbes that are difficult to culture throughconventional laboratory methods, enabling the creation of a large microbial genome database called bit-GEM. Its platform supports enzyme discovery, genome analysis, and bioengineering efforts aimed at developing bio-based alternatives for industrial processes. bitBiome also works with academic institutions and commercial partners on research projects involving areas such as biodegradable materials, biomass conversion, and pharmaceutical ingredient synthesis. The company positions microbes as a resource for advancing the bioeconomy by providing tools and data that support biotechnology research and industrial applications.
- POPS Worldwide — POPS Worldwide is the leading digital entertainment company in Southeast Asia. With over 4 billion monthly views of its music and entertainment content, POPS is the fastest growing digital entertainment media company with hundreds of artists, content creators and partners from broadcast television, publishing and production in the POPS Network.POPS also produces a wide variety of original content for its industry-leading owned and operated channels like POPS Music, POPS Kids, POPS TV, Beauty Me, HerVoice and CoolTV that target highly sought after demographics: teens, kids, women and men.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A, Series C
- Geography: China, United States, Singapore
Investor stats
- Total investments: 331
- Round size: Series A $2.9M–$165M; Series B $15M–$230M; Series C $15M–$220M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $11B in 2018
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Japan, United States, India
Investor stats
- Total investments: 215
- Round size: Seed $624k–$12M; Series A $2.3M–$18M; Venture - Series Unknown $2.2M–$13M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fresh fund, raised $326M in 2025
Portfolio highlights
- Mujin — At Mujin, we design automation platforms to enhance any robot, enable advanced capabilities and lower operating costs.
- RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
- United Immunity — Just another WordPress site
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Series A, Series B, Seed
- Geography: China, Singapore, Norway
Investor stats
- Total investments: 77
- Round size: Seed $10M–$120M; Series A $10M–$85M; Series B $14M–$99M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Yatsen Holding — Yasten provides high-quality fashion makeup products.
- kaye technology — Kaye Technology is a company that provides automation upgrade solutions for beverage equipment.
- Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Angel
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 154
- Round size: Angel $444k–$15M; Series A $1.5M–$73M; Series B $8.5M–$90M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $430M in 2018
Portfolio highlights
- SeaArt — SeaArt AI is an all-in-one AI creativity community for art, videos, audio, and AI chats, where creators collaborate, spark inspiration, and grow together.
- Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
- Allygen Biologics — Allygen Biologics is a biotechnology company that provides research and development of targeted conjugate therapeutics.
Lenovo Capital and Incubator Group is an accelerator and venture capital firm.
Show more...Investment focus
- Industry: Manufacturing, Artificial Intelligence, Software
- Stage:Series A, Seed, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 347
- Round size: Seed $1.4M–$65M; Series A $1.5M–$74M; Series B $8M–$150M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $500M in 2016
Portfolio highlights
- SemiGraph — SemiGraph focuses on the research, development, and implementation of "3D intelligent interaction + ultimate aesthetics."
- Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
- SenseTime Medical — SenseTime Medical promotes the development and implementation of its medical big model and provides smart health solutions.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Japan, United States, Ethiopia
Investor stats
- Total investments: 327
- Round size: Seed $455k–$9.6M; Series A $1.2M–$12M; Venture - Series Unknown $899k–$7M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $92M in 2019
Portfolio highlights
- Indent — Indent creates products that help writers create original works such as novels, manga, screenplays, and game scenarios. They will work to create an environment in which artists can focus on their creations and enjoy sharing their work.
- Spectronix — Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology.
- Zeal Boxing Fitness — Zeal Boxing Fitness combines power of sports with the power of technology to provide a service that allows to enjoy fitness.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator". SBI Investment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Series B, Series A, Venture - Series Unknown
- Geography: Japan, United States, South Korea
Investor stats
- Total investments: 456
- Round size: Series A $1.9M–$28M; Series B $4.5M–$62M; Venture - Series Unknown $1.3M–$20M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $77M in 2020
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
- Zerodoor HD — Zerodoor HD specializes in digital transformation in constructing industry.
DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, which often overlap or serve as an application layer.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan, United States, India
Investor stats
- Total investments: 89
- Round size: Seed $679k–$6M; Series A $3M–$10M; Venture - Series Unknown $367k–$19M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- New Chat — New Chat is a technology company that develops communication software focused on visual and interactive group interactions. The company builds platforms designed to help small, close-knit groups of people share daily experiences through short-form multimedia content. Its primary software automates the creation of collaborative video logs byprompting users for brief, periodic updates throughout the day. By structuring messaging around shared visual moments, the business aims to provide an alternative to traditional text-based group chats and standard social media networking.
- First Coffee — Discover the best specialty coffee in India with our range of single origin Arabica beans and exclusive merchandise. Shop online at First Coffee for freshly roasted, quality blends.
- Tellus Global — Tellus Global is a company focused on creating new businesses using satellite data, AI, and software technologies,Its core mission is to make satellite information accessible and useful across industries such as agriculture, environmental conservation, construction, finance, and disaster management.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services. 2) Agri-Food: Industrialization, agricultural and fishery products growth-promoting technology, specified health food, health food. 3) Environment, Energy: Alternative energy, and related technologies. 4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot. 5) New services utilizing state-of-art technology. Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 54
- Round size: Seed $395k–$19M; Series A $2M–$21M; Series B $3.7M–$150M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $91M in 2019
Portfolio highlights
- Mui Lab — Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- United Immunity — Just another WordPress site
Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Robotics
- Stage:Series A, Seed, Series B
- Geography: China, United States, Singapore
Investor stats
- Total investments: 243
- Round size: Seed $1.9M–$28M; Series A $1.5M–$43M; Series B $8M–$123M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — raised $141M in 2023
Portfolio highlights
- Sondit — Sondit specializes in R&D and manufacturing of civilian radar systems. It includes intelligent transportation, intelligent security, vehicle-road coordination, and other fields. It engaged in traffic information monitoring and urban traffic management in the field of the intelligent transportation industry.
- Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
- Differential Robotics — Differential Robotics is a robotics company providing research, design, and development of aerial robots and intelligent autonomous drones.
Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.
Show more...Investment focus
- Industry: Manufacturing, Semiconductor, Medical
- Stage:Series A, Seed, Series B
- Geography: China, United States
Investor stats
- Total investments: 42
- Round size: Series A $1.4M–$70M; Series B $11M–$139M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- CiMicro.Ai — CiMicro.ai is an AI‑chip startup building compute‑in‑memory (CiM)‑based heterogeneous accelerators for high‑efficiency, low‑cost large‑language‑model inference.
- Ruimeng Semiconductor — Ruimeng Semiconductor is a provider of intelligent human-machine interface processor chips and solutions.
- Baisheng Smart Computing — Baisheng Smart Computing specializes in the field of information technology application innovation, operations, and maintenance.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Japan
Investor stats
- Total investments: 93
- Round size: Seed $480k–$4.5M; Series A $1.5M–$19M; Venture - Series Unknown $751k–$3.5M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $92M in 2021
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- LQUOM — QWAVE offers cryptography communication technology.
- RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 148
- Round size: Seed $316k–$6M; Series A $2.1M–$15M; Venture - Series Unknown $438k–$10M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- JAOPS — JAOPS is dedicated to Operations as a Service and develops software, tools, and services for space mission operations, including data processing, mission planning, context evaluation, anomaly resolution, and real-time mission control and monitoring. The company provides mission operations design, training, and certification for operators, astronauts, and ground segment teams. JAOPS offers products such as Yamcs Gateway, mission control tools, and simulation environments to support spacecraft and lunar rover missions. Its services include turnkey mission control center design and deployment, operational reviews, and operations as a service. JAOPS works with open-source platforms like Yamcs, Grafana, and robotics simulators to support Earth orbit, cislunar, and lunar surface missions.
- Eco-Pork — Eco-Pork is a co-creation solution farm that supports farmers' food productivity improvement. It is connecting the pig and technology, pork ( Pork ) new business ecosystems ( Ecosystem By building a), in the pork growing demand around the world, to get the most out of the food supply capacity is finite.
- Teragen Energy — Teragen Energy develops an energy technology platform based on advanced regenerative solid oxide fuel cells that provide both power generation and energy storage in a single system. The company’s systems generate electricity from external fuels such as natural gas or hydrogen without combustion and can operate in reverse to store power as hydrogen.Teragen designs modular systems that can be scaled from megawatt-scale installations for data centers to deployments for microgrids, renewable projects, and utilities. Its technology is intended to help operators manage variable renewable output, ride through outages, and address daily capacity needs using one device. Teragen focuses on applications including AI and cloud data centers, manufacturing and cold storage facilities, remote communities, and electric grid infrastructure. The platform is positioned to replace separate diesel generators and battery systems by combining fuel-flexible generation and low-cost storage in a compact footprint.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VC Institutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 85
- Round size: Series A $1.4M–$36M; Series B $14M–$100M; Series C $14M–$74M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Xinyun Life — Xinyun Life Sciences is a high tech medical enterprise focusing on the R&D and industrialization of artificial intelligence vascular intervention devices. The company integrates AI deeply into its hardware development using a unique dual closed- oop system.
- Glimmer Gene — Glimmer Gene develops a comprehensive gene editing and epigenetic toolkit with independent intellectual property rights.
- Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies. Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have gone on to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors. Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 712
- Round size: Seed $1.2M–$74M; Series A $2.9M–$52M; Series B $10M–$137M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $92M in 2023
Portfolio highlights
- Camera360 — Camera360 is a mobile phone camera application. Through a variety of solutions, including Camera360 Ultimate, HelloCamera, Movie360, Pink360, Camera360 Cloud, Camera360 SDK and Web Camera360, Camera360 hopes to build an ecosystem for the modern creatives to capture, compose and share the beautiful moments of their lives.
- DiffuSpace — DiffuSpace is an artificial intelligence initiative dedicated to building diffusion language models to establish a new foundation model paradigm beyond traditional autoregression. Instead of generating text sequentially token by token, their technology focuses on thinking globally and evolving through uncertainty.
- Liepin — Liepin is the largest and most professional high-end talent community-based recruitment site, with its innovative products and unique service model model for create an interactive high-end talent recruitment platform between business, headhunting and workplace. Tens of thousands of professional executive search consultant for businesses and jobseekers set up communication between the bridge and accelerate corporate recruitment process, recommended paying jobs in the workplace, career development planning. 16 job seekers to avoid the risk of privacy protection, millions of high-end elite member libraries, help enterprises development needs.
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: China, India, Canada
Investor stats
- Total investments: 143
- Round size: Seed $512k–$5M; Series A $3M–$17M; Series B $3.2M–$50M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Vibronix — Vibronix innovates for Precision Healthcare with spectroscopic imaging, optical & acoustic sensing, and machine learning.
- PowerMicro — PowerMicro focuses on the cutting-edge interdisciplinary field of “stem cells + engineered scaffolds,” specializing in the application of iPSC technology to advance regenerative medicine, tissue engineering, and innovative therapeutic solutions.
- NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 60
- Round size: Series A $2.9M–$45M; Series B $13M–$61M; Series C $15M–$100M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Simnova — Simnova Biotherapeutics is a biopharmaceutical company that focuses on the research and development of cell therapies for cancer treatment. The company's primary therapeutic focus is CAR-based cell therapy for patients with either hematologic malignancies or solid tumors. Simnova Biotherapeutics is known for its innovative approach todeveloping patient-centered therapeutics using current science and technology. The company's lead product is SNC102, a cell therapy product that has been approved for clinical trials. Simnova Biotherapeutics is committed to creating a healthy, inclusive, and harmonious working environment.
- Deep Cell — Deep Cell is a Chinese AI driven drug discovery and virtual cell modeling startup. The company integrates artificial intelligence with multi scale molecular physics to construct explainable virtual cell world models, aiming to revolutionize paradigm shifting drug designs and simulate cellular responses to complex diseases.
- Accro Bioscience — Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.
CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: China, United States, Japan
Investor stats
- Total investments: 107
- Round size: Series A $3.2M–$230M; Series B $7.2M–$50M; Series C $10M–$220M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $2.8B in 2018
Portfolio highlights
- Yudao Bio — Yudo Bio provides biopharmaceutical products. It has its headquarters in Shanghai in China.
- Spectronix — Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology.
- Xuntu Technology — Xuntu Technology is a leading data intelligence provider specializing in investment research and decision-making solutions.
Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Show more...Investment focus
- Industry: Information Technology, Software, Consulting
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 73
- Round size: Seed $792k–$28M; Series A $2.5M–$19M; Series B $6.5M–$47M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $152M in 2019
Portfolio highlights
- Recerqa — Recerqa is a supply chain management SaaS that utilizes advanced development technology and AI to improve the purchasing, inventory, and sales management experiences.
- Mign — Mign offers a generative AI-related SaaS solutions for the construction and real estate fields.
- Henry — Henry develops and provides a cloud-based electronic medical record and receipt system for small and medium-sized hospitals.
Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and Technology Agency. Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan. Japan Science and Technology Agency is headquartered in Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Medical, Manufacturing
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Japan
Investor stats
- Total investments: 56
- Round size: Seed $1.7M–$5M; Series A $2.3M–$15M; Venture - Series Unknown $975k–$9.8M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Triorb — The corporate website of TriOrb Inc., revolutionizing production lines with our ball-driven omnidirectional mobility platform.
- ANRis — ANRis is a hybrid drug discovery venture that develops medicines to provide medical care for patients with cancer and genetic diseases.
- Solaris — Solaris commercializes, manufactures, and sells soft robotics using pneumatic artificial muscles. Solaris was founded in 2017 and was headquartered in Tokyo, Japan.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: China, United States, South Korea
Investor stats
- Total investments: 400
- Round size: Series A $2.9M–$40M; Series B $8.8M–$56M; Venture - Series Unknown $1.5M–$60M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $375M in 2021
Portfolio highlights
- Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
- Moge Microflow — Moge Microflow is a manufacturer of equipment for microreactors. It provides continuous flow production technologies and equipment for nanomaterials, pharmaceutical intermediates, and fine chemicals, as well as standardized high-end microreactor equipment.
- Bianzhong New Materials — Bianzhong New Materials is a high-tech company that specializes in the research and development of equipment for weaving and shaping three-dimensional preforms of high-strength fiber composite materials.
Longpan Investment is an investment firm.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: China, United States, Cayman Islands
Investor stats
- Total investments: 44
- Round size: Seed $14M–$60M; Series A $14M–$32M; Series B $14M–$37M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Jingling Zhikang — Jingling Zhikang is technology company specializing in the intersection of medical rehabilitation, robotics, and embodied artificial intelligence. The company focuses on developing intelligent rehabilitation bionic hands and upper-limb prosthetics.
- Hanyue New Materials — Hanyue Advanced Materials is a high-tech company that specializes in single-use biopharmaceutical solutions.
- Lingtai Krypton Biotechnology — Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Japan, United States, India
Investor stats
- Total investments: 395
- Round size: Seed $288k–$7.1M; Series A $1.8M–$20M; Venture - Series Unknown $368k–$9.2M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $127M in 2024
Portfolio highlights
- Akari Hosho — Akari Hosho provides a group of trusted professionals, including lawyers and judicial scriveners. Akari Hosho provides a guarantee service.
- Black Cat Carnival — Tell us about anything development-related. Our founder, who launched Niconico Live, SUGAR and GANMA! from scratch, helps with planning, design, development and operations.
- Carbon CryoCapture — Carbon CryoCapture specializes in the carbon dioxide separation systems aimed at creating economically viable, energy-efficient, and genuinely sustainable CO2 separation and recovery technologies. The company is dedicated to deploying cost-effective, efficient systems for CO2 capture that integrate smoothly with current infrastructures, all whileenhancing energy consumption and production. This enables clients to attain zero emissions throughout the development and application of resources.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!ASBV focuses on early and mid-term venture capital investments.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: China, Australia, Hong Kong
Investor stats
- Total investments: 28
- Round size: Seed $3M–$14M; Angel $471k–$485k; Series A $1.4M–$34M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 767
- Round size: Series A $9M–$116M; Series B $23M–$148M; Series C $19M–$160M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $192M in 2026
Portfolio highlights
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
- Bonovo Orthopedics —
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 254
- Round size: Series A $14M–$100M; Series B $25M–$110M; Series C $30M–$308M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
- NeuShen Therapeutics — We are a global biotech company committed to developing new and effective therapies for psychiatric and neurological disorders affecting millions of patients in need.
- Connexus Therapeutics — Connexus Therapeutics is a private, venture-backed biotechnology company specializing in the discovery and development of next-generation small-molecule drugs for oncology treatment .
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfolio sources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Kenya
Investor stats
- Total investments: 105
- Round size: Series A $7.2M–$50M; Series B $15M–$100M; Series C $21M–$128M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Shenfu Jianxing — Shenfu Jianxing is a brain-computer interface developer. It focuses on minimally invasive implanted brain-spinal interface technology, with "minimally invasive + low latency + high integration" as its core, to build implantable brain-spinal neural stimulation systems.
- Allygen Biologics — Allygen Biologics is a biotechnology company that provides research and development of targeted conjugate therapeutics.
- Archimedes Vascular — Archimedes Vascular operates as a medical device company, that treat patients with severe hypertension.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 49
- Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$187M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $250M in 2015
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Jiadao Capital is an investment Firm.
Show more...Investment focus
- Industry: Biotechnology, Medical, Manufacturing
- Stage:Angel, Seed, Series A
- Geography: China
Investor stats
- Total investments: 22
- Round size: Seed $2.2M–$15M; Angel $1.4M–$49M; Series A $15M–$15M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Rabbitpre — Rabbitpre is a big data-driven technology marketing company.
- Lead Health — Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights.
- Active Technology — Active Technology is a pioneering deep tech startup specialized in developing invasive brain computer interface (BCI) technology. The company integrates flexible electrodes, dedicated chips, and advanced decoding algorithms to target motor, visual, and emotional neural pathways.
Inspiration Capital is an investment firm.
Show more...Investment focus
- Industry: Manufacturing, Artificial Intelligence, Sensor
- Stage:Seed, Series A, Series B
- Geography: China
Investor stats
- Total investments: 23
- Round size: Seed $1.5M–$15M; Series A $16M–$16M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Youshu Quantum — Youshu Quantum is a deep-tech startup specializing in quantum computing software, middleware, and proprietary algorithms.
- Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
- Chipworld Optoelectronics — Shanghai Xinjie Guanghe Technology Co., Ltd. is a high-tech chip design enterprise specializing in the research, development, and engineering of all-optical interconnect platforms and silicon-based optical switching chips for artificial intelligence computing clusters.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 91
- Round size: Seed $826k–$14M; Series A $2.2M–$41M; Venture - Series Unknown $2M–$12M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $94M in 2020
Portfolio highlights
- ElleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
- Starlight Engine — Starlight Engine develops and commercializes fusion energy power plant technologies.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Tianjin Venture Capital is an investment firm.
Show more...Investment focus
- Industry: Manufacturing, Information Technology, Biotechnology
- Stage:Seed, Series A
- Geography: China, United States
Investor stats
- Total investments: 106
- Round size: Seed $413k–$15M; Series A $202k–$31M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
- Xingneng Xuanguang — Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology.
- Innovec Biotherapeutics — Innovec Biotherapeutics Specialized in gene therapy technology and medication development.
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more...Investment focus
- Industry: Manufacturing, Medical, Health Care
- Stage:Series A, Seed, Series B
- Geography: China, United States, India
Investor stats
- Total investments: 147
- Round size: Seed $1.4M–$4M; Series A $1.5M–$21M; Series B $3.1M–$84M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Tpson — Tpson is a Smart Hardware company.
- Ounuo Semiconductor — Ounuo Semiconductor is a manufacturing company that provides research and development of semiconductor equipment.
- HUAXI Technology — HUAXI Technology is a global leader specializing in the development and delivery of comprehensive, high-end smart elderly care solutions. By integrating advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), and big data analytics, the company is dedicated to enhancing the quality of life for seniors worldwide.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Temasek is a global investment company headquartered in Singapore with a multinational staff of over 960 people. Our portfolio is valued at S$434 billion.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series C, Series D
- Geography: United States, China, India
Investor stats
- Total investments: 669
- Round size: Series B $29M–$250M; Series C $28M–$400M; Series D $43M–$460M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — raised $283M in 2019
Portfolio highlights
- Vinci — Vinci runs massive simulations at nanometer resolution in minutes, validated for accuracy. The first foundation model for physics.
- Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
- Soufflé Therapeutics — Soufflé Therapeutics is a biotechnology company specializing in the development of nucleic acid medicines designed for precise delivery and targeting of disease-causing cells. The company's mission is to create potent, precise, and safe medicines that can be tailored for a broad range of diseases by leveraging breakthroughs in genetic medicineand drug delivery technology.
Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, Japan
Investor stats
- Total investments: 601
- Round size: Series A $1.5M–$128M; Series B $13M–$141M; Series C $4.4M–$156M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Prosemi — Pusenmei is a precision micro-resistance current sensor developer company committed to delivering professional and diverse precision micro-resistance current detecting resistors and circuit protection solutions.
- Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
- Waker Biology — Weike Bio is a gene therapy drug development company.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greater development space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services. Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns. Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise. By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 192
- Round size: Seed $7.9M–$41M; Series A $4.4M–$47M; Series B $7.1M–$85M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $204M in 2016
Portfolio highlights
- Inno Medicine — Inno Pharmaceutical Technology specializes in research on the pathogenesis of atherosclerosis. The company focuses on the development of targeted nanoliposomes, targeting molecules with independent intellectual property rights, and currently focuses on the plaque reversal treatment of atherosclerosis.
- Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
- MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Angel, Pre-Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 76
- Lead/follow: no public data
Portfolio highlights
- TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
- Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
- Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China. Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in China or on markets related to China. Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services. Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc. As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: China, United States, South Korea
Investor stats
- Total investments: 523
- Round size: Series A $2.9M–$93M; Series B $12M–$100M; Series C $15M–$200M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $177M in 2021
Portfolio highlights
- Z.ai — Z.ai develops artificial intelligence models and services built upon large-scale pretrained architectures. The company offers ChatGLM, a dialogue-focused language model series designed for smooth conversation and easy integration. It also provides Ying, a text-to-video model capable of generating short video clips from text or images, and AutoGLM,a voice-driven AI agent that performs smartphone tasks based on complex user instructions. Z.ai supports integration through an API platform and offers migration assistance for developers moving from other AI ecosystems. The company’s technology stems from research at Tsinghua University’s KEG lab and emphasizes general-purpose cognitive intelligence models.
- DiffuSpace — DiffuSpace is an artificial intelligence initiative dedicated to building diffusion language models to establish a new foundation model paradigm beyond traditional autoregression. Instead of generating text sequentially token by token, their technology focuses on thinking globally and evolving through uncertainty.
- Huixin Bio — Huixin Bio is a developer of exosome purification products and early cancer detection technology.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to the creations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Japan, United States, India
Investor stats
- Total investments: 370
- Round size: Series A $2.1M–$41M; Series B $4.2M–$36M; Venture - Series Unknown $1.4M–$13M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $567M in 2019
Portfolio highlights
- CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
- ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
- Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States
Investor stats
- Total investments: 73
- Round size: Seed $1.4M–$15M; Series A $1.5M–$32M; Series B $7.6M–$34M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Genlight — Genlight develops innovative treatment solutions for epilepsy and other neurological diseases. Genlight is headquartered in Hangzhou, China.
- Pipi Bear — Pipi Bear is a creator of living robots and health goods, with a focus on those that improve the lives of the elderly.
- CORE Biomedicine — CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology.
Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: China
Investor stats
- Total investments: 51
- Round size: Seed $7.9M–$15M; Series A $1.5M–$103M; Venture - Series Unknown $14M–$44M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- MemoraX AI — MemoraX AI is an innovator in the field of tailored memory for huge models.
- Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
- Xingkan Jiuzhou — Xingkan Jiuzhou is a technology-based enterprise specializing in radio signal reception, demodulation, analysis, and transmitter location.
ULTIMA is an investment management firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Fitness
- Stage:Angel, Series A, Series B
- Geography: China
Investor stats
- Total investments: 7
- Round size: Angel $462k–$1.6M; Series A $1.5M–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
- HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo. The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is the fifth-largest venture capital firm in Japan. Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 550
- Round size: Series A $1.4M–$32M; Series B $2.4M–$47M; Venture - Series Unknown $661k–$11M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $92M in 2020
Portfolio highlights
- CaTe — CaTe is based in Tokyo. CaTe develops and manufactures a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their invention allows heart disease patients to safely and successfully complete cardiac rehabilitation utilizing standing exercise in a confined space, such as at home, without the use of ergometers or similar instruments.
- Flyle — Flyle provides a cloud based platform for product management helping customers to improve productivity & creativity in product development.
- HEARTBEATS — HEARTBEATS builds fan engagement platforms and digital experiences for sports teams, artists, and entertainment brands.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Asia Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!